JMP Securities initiated coverage on Global Medical REIT
$GMRE
Real Estate Investment Trusts
Real Estate
JMP Securities initiated coverage of Global Medical REIT with a rating of Mkt Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/3/2025 | $9.00 | Neutral | B. Riley Securities |
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc | |
| 9/20/2021 | $17.00 | Overweight | Keybanc |
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
10-Q - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that its Board of Directors (the "Board") approved a $50 million common stock repurchase program and reverse stock split of the Company's common stock at a ratio of one-for-five. Common Stock Repurchase Program On August 12, 2025, the Board approved a $50 million common stock repurchase program (the "Program"). Under the Program, the Company may purchase up to $50 million of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), from time to time in the open market, including through block purchases, through privately negotiated transactions or pursuant to any Rule 10b5-1 tradin
– Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and six months ended June 30, 2025 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "I'm excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the bu
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, August 6, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alfonzo Leon. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's website at https://investors.globalmedica
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that its Board of Directors (the "Board") approved a $50 million common stock repurchase program and reverse stock split of the Company's common stock at a ratio of one-for-five. Common Stock Repurchase Program On August 12, 2025, the Board approved a $50 million common stock repurchase program (the "Program"). Under the Program, the Company may purchase up to $50 million of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), from time to time in the open market, including through block purchases, through privately negotiated transactions or pursuant to any Rule 10b5-1 tradin
– Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and six months ended June 30, 2025 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "I'm excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the bu
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its second quarter 2025 financial results after the market closes on Tuesday, August 5, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, August 6, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alfonzo Leon. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's website at https://investors.globalmedica
Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,